Related Experiment Video
Updated: Jun 19, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
Arginine-pyrimidine conjugates with therapeutic and prophylactic activity in lethal bacterial infections
Dieter Haebich1, Hein-Peter Kroll, Hans-Georg Lerchen
1Medicinal Chemistry, Bayer Schering Pharma AG, D-42096 Wuppertal, Germany. dieter.haebich@bayerhealthcare.com
Abstract:
Arginine-pyrimidine conjugates represent a novel class of compounds that exhibits therapeutic and prophylactic activity in lethal infections by Gram-positive and Gram-negative bacteria without showing antibacterial activity in vitro.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Physical Properties of Amines
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Acute Pyelonephritis II: Diagnostic Studies and Management
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
